Organ-specific dosimetry to estimate potential toxicity thresholds of Actimab-A (lintuzumab-Ac225) used in combination with venetoclax in relapsed/refractory AML-MedSci.cn

Organ-specific dosimetry to estimate potential toxicity thresholds of Actimab-A (lintuzumab-Ac225) used in combination with venetoclax in relapsed/refractory AML

Chen, M; Brodin, P; Syed, U; McNamara, K; Spross, J; Haeuber, E; Desai, A

JOURNAL OF NUCLEAR MEDICINE, 2023; 64 ():

科室
- - 订阅+
  - 更多科室
工具
服务